Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Cost tracking Pharmacy comparison, monthly spend, and savings goals
Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification
Many group health plans limit coverage of new technologies and medications to those that have FDA approval for the treatment of a particular condition
Unlike unregulated, research-grade peptides sourced from overseas, this is a physician-guided therapy designed for safety, accuracy, and real outcomes
US$ 29.18
US$ 22.02
US$ 24.34
